SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-251407
Filing Date
2017-08-08
Accepted
2017-08-08 16:32:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d438986ds3.htm S-3 332412
2 EX-1.2 d438986dex12.htm EX-1.2 148377
3 EX-5.1 d438986dex51.htm EX-5.1 14808
4 EX-23.1 d438986dex231.htm EX-23.1 1563
5 GRAPHIC g438986g0808112850594.jpg GRAPHIC 2556
6 GRAPHIC g438986g67p22.jpg GRAPHIC 33874
  Complete submission text file 0001193125-17-251407.txt   548626
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219791 | Film No.: 171015257
SIC: 2834 Pharmaceutical Preparations